89 related articles for article (PubMed ID: 10875228)
1. A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain.
Evans SJ; Searcy BT; Moore FL
Endocrinology; 2000 Jul; 141(7):2294-300. PubMed ID: 10875228
[TBL] [Abstract][Full Text] [Related]
2. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa.
Bradford CS; Walthers EA; Searcy BT; Moore FL
J Mol Endocrinol; 2005 Jun; 34(3):809-23. PubMed ID: 15956349
[TBL] [Abstract][Full Text] [Related]
3. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
Tiberi M; Magnan J
Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
6. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
7. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
Butelman ER; Ko MC; Sobczyk-Kojiro K; Mosberg HI; Van Bemmel B; Zernig G; Woods JH
J Pharmacol Exp Ther; 1998 May; 285(2):595-601. PubMed ID: 9580603
[TBL] [Abstract][Full Text] [Related]
8. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
9. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and pharmacological characterization of a glucocorticoid membrane receptor from an amphibian brain.
Evans SJ; Moore FL; Murray TF
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):1-8. PubMed ID: 9780023
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding profiles of U-69, 593-sensitive and-insensitive sites in human cerebral cortex membranes: evidence of kappa opioid receptors heterogeneity.
Kim KW; Eun YA; Soh SM; Eun JS; Cho KP
Life Sci; 1996; 58(19):1671-9. PubMed ID: 8632704
[TBL] [Abstract][Full Text] [Related]
12. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
Garzón J; Sánchez-Blázquez P; Lee NM
J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
[TBL] [Abstract][Full Text] [Related]
13. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
Townsend D; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
[TBL] [Abstract][Full Text] [Related]
14. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
15. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
[TBL] [Abstract][Full Text] [Related]
16. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
17. Evidence for kappa 1 opioid receptor multiplicity in the guinea pig cerebellum.
Kinouchi K; Pasternak GW
Eur J Pharmacol; 1991 Jun; 207(2):135-41. PubMed ID: 1679014
[TBL] [Abstract][Full Text] [Related]
18. kappa-Opioid binding sites on a murine lymphoma cell line.
Bidlack JM; Saripalli LD; Lawrence DM
Eur J Pharmacol; 1992 Nov; 227(3):257-65. PubMed ID: 1335414
[TBL] [Abstract][Full Text] [Related]
19. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
Hjorth SA; Thirstrup K; Schwartz TW
Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
[TBL] [Abstract][Full Text] [Related]
20. Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa.
Walthers EA; Bradford CS; Moore FL
J Mol Endocrinol; 2005 Feb; 34(1):247-56. PubMed ID: 15691892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
